宣泰医药(688247.SH)发预减，预计2025年归母净利润4507万元至5408万元，同比下降57.65%至64.71%

Group 1 - The company expects to achieve a net profit attributable to shareholders of the parent company between 45.07 million and 54.08 million yuan for the year 2025, which represents a decrease of 73.62 million to 82.63 million yuan compared to the previous year [1] - The anticipated decline in net profit corresponds to a year-on-year decrease of 57.65% to 64.71% [1]